Empresa española desarrolla los primeros hisopos por fabricación aditiva para PCR en el país
Recientemente, la empresa española Temi Group Corporation (TGC), ha cerrado un acuerdo con el Hospital Virtual Valdecilla (HvV) para la fabricación con tecnología 3D de hisopos nasofaríngeos, piezas fundamentales en las pruebas PCR, que permiten detectar si una persona está infectada o no por coronavirus. Los hisopos permiten arrastrar fragmentos del material biológico necesario para identificar el Covid-19 cuando se realiza la prueba de diagnóstico mediante PCR.
La planta de fabricación de TGC está ubicada en la provincia de Castellón, Valencia.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Carrer Batalla De Muret, Nave 24 A,spain
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- HQ
- Almazora/Almassora, Comunidad Valenciana / Comunitat Valenciana
Medical Temigroup Questions
Medical Temigroup's website is https://temigroupcorporation.com/
Medical Temigroup's LinkedIn profile is https://es.linkedin.com/company/medical-temigroup
Medical Temigroup has
3 employees.
View email and phone details for 3
employees at Medical Temigroup.
Medical Temigroup's industry is
Research Services
Medical Temigroup's top competitors are
Cauprotect,
Aramobel,
Ingeniería Mavic,
Lepere Contract Group,
Fundación Universitat Jaume I-Empresa (Fue-Uji),
Stat-Dx,
Summumstudio "design That Makes A Difference",
Mediterraneo Vdl Sl,
Limitronic,
Sastre & Asociados S.l.
Medical Temigroup's categories are Research Services
Medical Temigroup's founding year is 2020
